Olaf Walter
Board Member
octapharma
Austria
Biography
The International Business Units have developed significantly over the past few years. I’m proud of the results that the IBU’s have accomplished so far and I’m hoping that the three teams from haematology, immunotherapy, and critical care will develop even stronger ties to the markets in the future.”
Research Interest
MEDICINE
